Bank of America Corporation 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-31 3:15 pm Sale |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
BANK OF AMERICA CORP BAC |
1,603,685 2.500% |
-4,279,893 (-72.74%) |
Filing |
| 2021-02-08 5:14 pm Purchase |
2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
BANK OF AMERICA CORP BAC |
5,883,578 9.500% |
1,185,435 (+25.23%) |
Filing |